Cargando…
Let-7f-5p suppresses Th17 differentiation via targeting STAT3 in multiple sclerosis
T helper 17 (Th17) cells are regarded as key factors in the pathogenesis of multiple sclerosis (MS). Although the involvement of certain microRNAs (miRNAs) in the development of MS has been reported, their roles in Th17 cell differentiation and MS pathogenesis remain elusive. In this study, we ident...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660039/ https://www.ncbi.nlm.nih.gov/pubmed/31326963 http://dx.doi.org/10.18632/aging.102093 |
_version_ | 1783439245115916288 |
---|---|
author | Li, Zhi-Hui Wang, Yi-Fei He, Dan-Dan Zhang, Xue-Mei Zhou, Ying-Lian Yue, Hui Huang, Shan Fu, Zheng Zhang, Ling-Yu Mao, Zhu-Qing Li, Shuang Zhang, Chen-Yu Chen, Xi Fu, Jin |
author_facet | Li, Zhi-Hui Wang, Yi-Fei He, Dan-Dan Zhang, Xue-Mei Zhou, Ying-Lian Yue, Hui Huang, Shan Fu, Zheng Zhang, Ling-Yu Mao, Zhu-Qing Li, Shuang Zhang, Chen-Yu Chen, Xi Fu, Jin |
author_sort | Li, Zhi-Hui |
collection | PubMed |
description | T helper 17 (Th17) cells are regarded as key factors in the pathogenesis of multiple sclerosis (MS). Although the involvement of certain microRNAs (miRNAs) in the development of MS has been reported, their roles in Th17 cell differentiation and MS pathogenesis remain elusive. In this study, we identified that let-7f-5p expression is significantly downregulated in CD4(+) T cells from MS patients and during the process of Th17 differentiation. The overexpression of let-7f-5p suppressed Th17 differentiation, whereas the knockdown of let-7f-5p expression enhanced this progress. We then explored the molecular mechanism through which let-7f-5p suppressed Th17 differentiation and identified signal transducer and activator of transcription 3 (STAT3), a pivotal transcription factor of Th17 cells, as a direct target of let-7f-5p. In contrast to the downregulated expression of let-7f-5p, STAT3 and p-STAT3 protein levels were dramatically upregulated and inversely correlated with let-7f-5p in peripheral blood CD4(+) T cells from MS patients. In conclusion, let-7f-5p functions as a potential inhibitor of Th17 differentiation in the pathogenesis of MS by targeting STAT3 and may serve as a new therapeutic target. |
format | Online Article Text |
id | pubmed-6660039 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Impact Journals |
record_format | MEDLINE/PubMed |
spelling | pubmed-66600392019-08-05 Let-7f-5p suppresses Th17 differentiation via targeting STAT3 in multiple sclerosis Li, Zhi-Hui Wang, Yi-Fei He, Dan-Dan Zhang, Xue-Mei Zhou, Ying-Lian Yue, Hui Huang, Shan Fu, Zheng Zhang, Ling-Yu Mao, Zhu-Qing Li, Shuang Zhang, Chen-Yu Chen, Xi Fu, Jin Aging (Albany NY) Research Paper T helper 17 (Th17) cells are regarded as key factors in the pathogenesis of multiple sclerosis (MS). Although the involvement of certain microRNAs (miRNAs) in the development of MS has been reported, their roles in Th17 cell differentiation and MS pathogenesis remain elusive. In this study, we identified that let-7f-5p expression is significantly downregulated in CD4(+) T cells from MS patients and during the process of Th17 differentiation. The overexpression of let-7f-5p suppressed Th17 differentiation, whereas the knockdown of let-7f-5p expression enhanced this progress. We then explored the molecular mechanism through which let-7f-5p suppressed Th17 differentiation and identified signal transducer and activator of transcription 3 (STAT3), a pivotal transcription factor of Th17 cells, as a direct target of let-7f-5p. In contrast to the downregulated expression of let-7f-5p, STAT3 and p-STAT3 protein levels were dramatically upregulated and inversely correlated with let-7f-5p in peripheral blood CD4(+) T cells from MS patients. In conclusion, let-7f-5p functions as a potential inhibitor of Th17 differentiation in the pathogenesis of MS by targeting STAT3 and may serve as a new therapeutic target. Impact Journals 2019-07-15 /pmc/articles/PMC6660039/ /pubmed/31326963 http://dx.doi.org/10.18632/aging.102093 Text en Copyright © 2019 Li et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY) 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Paper Li, Zhi-Hui Wang, Yi-Fei He, Dan-Dan Zhang, Xue-Mei Zhou, Ying-Lian Yue, Hui Huang, Shan Fu, Zheng Zhang, Ling-Yu Mao, Zhu-Qing Li, Shuang Zhang, Chen-Yu Chen, Xi Fu, Jin Let-7f-5p suppresses Th17 differentiation via targeting STAT3 in multiple sclerosis |
title | Let-7f-5p suppresses Th17 differentiation via targeting STAT3 in multiple sclerosis |
title_full | Let-7f-5p suppresses Th17 differentiation via targeting STAT3 in multiple sclerosis |
title_fullStr | Let-7f-5p suppresses Th17 differentiation via targeting STAT3 in multiple sclerosis |
title_full_unstemmed | Let-7f-5p suppresses Th17 differentiation via targeting STAT3 in multiple sclerosis |
title_short | Let-7f-5p suppresses Th17 differentiation via targeting STAT3 in multiple sclerosis |
title_sort | let-7f-5p suppresses th17 differentiation via targeting stat3 in multiple sclerosis |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660039/ https://www.ncbi.nlm.nih.gov/pubmed/31326963 http://dx.doi.org/10.18632/aging.102093 |
work_keys_str_mv | AT lizhihui let7f5psuppressesth17differentiationviatargetingstat3inmultiplesclerosis AT wangyifei let7f5psuppressesth17differentiationviatargetingstat3inmultiplesclerosis AT hedandan let7f5psuppressesth17differentiationviatargetingstat3inmultiplesclerosis AT zhangxuemei let7f5psuppressesth17differentiationviatargetingstat3inmultiplesclerosis AT zhouyinglian let7f5psuppressesth17differentiationviatargetingstat3inmultiplesclerosis AT yuehui let7f5psuppressesth17differentiationviatargetingstat3inmultiplesclerosis AT huangshan let7f5psuppressesth17differentiationviatargetingstat3inmultiplesclerosis AT fuzheng let7f5psuppressesth17differentiationviatargetingstat3inmultiplesclerosis AT zhanglingyu let7f5psuppressesth17differentiationviatargetingstat3inmultiplesclerosis AT maozhuqing let7f5psuppressesth17differentiationviatargetingstat3inmultiplesclerosis AT lishuang let7f5psuppressesth17differentiationviatargetingstat3inmultiplesclerosis AT zhangchenyu let7f5psuppressesth17differentiationviatargetingstat3inmultiplesclerosis AT chenxi let7f5psuppressesth17differentiationviatargetingstat3inmultiplesclerosis AT fujin let7f5psuppressesth17differentiationviatargetingstat3inmultiplesclerosis |